A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse
Philip R Davidson1, Amy L Sherborne2, Barry Taylor3
1Department of Finance and Statistical Analysis, University of Alberta, Edmonton, Alberta, T6G 2R3, Canada.
Scientific Reports
|August 11, 2017
Summary
Combining mouse and human cancer data using non-negative matrix factorization (NMF) helps identify distinct mutational signatures. This approach clarifies ionizing radiation (IR) mutagenesis, even with limited human samples.
Area of Science:
- Cancer Genomics
- Mutational Signatures Analysis
- Comparative Oncology
Background:
- Single nucleotide variants (SNVs) in cancer genomes can reveal mutational signatures linked to specific carcinogens.
- Non-negative matrix factorization (NMF) is a computational method used to de-convolute SNVs into mutational signatures.
- The accuracy of NMF-derived signatures is dependent on the quantity of available sequencing data, which is often limited for certain cancer types, particularly those induced by ionizing radiation (IR).
Purpose of the Study:
- To evaluate if data from mouse models can supplement scarce human data for cancer mutational signature analysis.
- To define the mutational processes associated with ionizing radiation (IR) in vivo.
- To determine if IR-induced mutational signatures can be distinguished from other mutagenic processes.
Main Methods:
- Pooled sequencing data from mouse models and human subjects exposed to ionizing radiation (IR).
- Inclusion of data from ultraviolet radiation (UV)-induced human skin cancer and urethane-induced mouse cancer for comparative analysis.
- Application of non-negative matrix factorization (NMF) to de-convolute SNVs and identify trinucleotide-based mutational signatures.
Main Results:
- NMF successfully distinguished mutational signatures from three distinct mutagenic agents: ionizing radiation (IR), ultraviolet radiation (UV), and urethane.
- In a pooled analysis of mouse and human data, IR exposure was associated with conserved mutational signatures across both species.
- The study demonstrated that combining data from mouse models and human subjects enhances the identification and characterization of mutational signatures.
Conclusions:
- Pooled analysis of mouse and human sequencing data is a valuable strategy to overcome data scarcity in cancer genomics.
- This approach aids in defining and differentiating mutational signatures, particularly for poorly characterized mutagenic processes like IR-induced mutagenesis.
- The findings highlight the utility of integrating animal model data with human data for robust cancer research.
Related Concept Videos
Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Mismatch Repair
6.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K


